September 11, 2025

Prognostic Value of Molecular and Clinical Features in Patients with NPM1 Gene Mutation in Acute Myeloid Leukemia.

View Full Paper

Ask AI

Bookmark

Authors

XLXiaoyu LiQingdao University KXKaiqiang Xi

Discussion

Member takes

Implication

Retrospective analysis of clinical features and molecular abnormalities reveals adverse prognosis in NPM1-mutated AML patients, suggesting intensified therapy may be needed.

Key Points

NPM1 mutations significantly influence clinical outcomes in acute myeloid leukemia, necessitating targeted treatment strategies.
Survival analysis shows that FLT3-ITD and DNMT3A mutations are key factors impacting recurrence-free and overall survival rates.
Multivariate analysis identified elevated WBC count and increased LDH levels as independent adverse factors affecting prognosis for AML patients.
Allogeneic hematopoietic stem cell transplantation may offer a protective effect, underscoring the need for careful treatment decision-making.

Cite This Study

Li et al. (2025) studied this question.

synapsesocial.com/papers/68c2a9cb04ab598fffb89e85 https://doi.org/10.7754/clin.lab.2022.250132

View Full Paper

Ask AI

Bookmark

Implication

Retrospective analysis of clinical features and molecular abnormalities reveals adverse prognosis in NPM1-mutated AML patients, suggesting intensified therapy may be needed.

Prognostic Value of Molecular and Clinical Features in Patients with NPM1 Gene Mutation in Acute Myeloid Leukemia.

Discussion

Member takes

Implication

Key Points

Cite This Study

Prognostic Value of Molecular and Clinical Features in Patients with NPM1 Gene Mutation in Acute Myeloid Leukemia.

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider